Breaking News
March 20, 2019 - Biohaven’s Verdiperstat Receives Orphan Drug Designation From FDA For Multiple System Atrophy
March 20, 2019 - Smoking may limit body’s ability to fight dangerous form of skin cancer
March 20, 2019 - Researchers receive $9.7-million grant to develop new hearing-loss treatments for deaf
March 20, 2019 - TGen and ABL sign agreement to distribute new TB test technology
March 20, 2019 - UCD researchers lead development of new urine test to detect prostate cancer
March 20, 2019 - Miniature brains that can move muscles, grown in the lab
March 20, 2019 - Servier and Oncodesign announce research and drug development partnership
March 20, 2019 - FDA warns marketer of unapproved products claiming to treat addiction, chronic pain
March 20, 2019 - TB Medicine Pretomanid Enters Regulatory Review Process in the United States
March 20, 2019 - Breastfeeding can erase effects of prenatal violence for newborns
March 20, 2019 - Tens of Thousands of Heart Patients May Not Need Open-Heart Surgery
March 20, 2019 - Space worries – shingles affecting astronauts says NASA
March 20, 2019 - Study shows how AI can improve physicians’ diagnostic accuracy
March 20, 2019 - Dolomite Bio launches new scRNA-Seq Reagent Kit at AGBT 2019
March 20, 2019 - World’s oldest semen viable for artificial insemination
March 20, 2019 - FDA Approves Zulresso (brexanolone) for the Treatment of Post-Partum Depression
March 19, 2019 - How it manipulates us to tribalism
March 19, 2019 - How can doctors encourage patients to adopt healthier behaviors?
March 19, 2019 - Meet Hal: He's One Sick Robot
March 19, 2019 - Blood test and mathematical model can estimate preterm birth rate in low-resource countries
March 19, 2019 - TAVR procedure safe in patients with unusual valve anatomy
March 19, 2019 - Proteins in the eye may be potential source for cost-effective test to predict Alzheimer’s disease
March 19, 2019 - Opioid Prescriptions Dropped for New Users From 2012 to 2017
March 19, 2019 - New method may better predict the best treatment for burn wounds
March 19, 2019 - “Asian” isn’t specific enough for health data, research suggests
March 19, 2019 - ColumbiaDoctors Presents Honors for Outstanding Commitment to Patient Safety
March 19, 2019 - Innovative model identifies primate species with potential to transmit Zika in the Americas
March 19, 2019 - One-off surgery could offer hope to patients with high blood pressure
March 19, 2019 - Many pet owners interested in feeding their pets with plant-based diet
March 19, 2019 - How to Protect Your Kids From Drowning
March 19, 2019 - CEA Test: MedlinePlus Lab Test Information
March 19, 2019 - Two years after face transplant, Andy Sandness’ smile shows his progress
March 19, 2019 - Registration now open for Stanford’s Big Data in Precision Health conference
March 19, 2019 - Gene Keeps Fear at Bay, But Only in Females
March 19, 2019 - Cholesterol lowering drug can also help treat cancer-associated cachexia
March 19, 2019 - GARDP and Evotec partner to tackle growing threat of antimicrobial resistance
March 19, 2019 - Ultrasound offers precise, minimally invasive way to measure cardiac output in children
March 19, 2019 - Study suggests potential new approach to treat atopic dermatitis
March 19, 2019 - Sense of control over life makes older adults feel younger
March 19, 2019 - Study shows how probiotics influence gut microbiota
March 19, 2019 - Study offers new evidence that narcolepsy is an autoimmune condition
March 19, 2019 - Breastfeeding may offer long-term heart health benefits for women
March 19, 2019 - Study of young athletes suggests snoring and sleep apnea are linked to sudden cardiac death
March 19, 2019 - Did Your Doctor ‘Ghost’ You? An Employment Contract May Be To Blame
March 19, 2019 - Food pantry clients more likely to make healthy choices when meal kits and recipe tastings are available
March 19, 2019 - Mental health problems among children increasing
March 19, 2019 - New ISO standard helps evaluate and manage impact of environmental damage
March 19, 2019 - CardioMEMS heart failure sensor reliably safe, effectively reduces hospitalizations
March 19, 2019 - Researchers report promising results of potential reversal agent
March 19, 2019 - Scientists identify brain circuit responsible for cocaine-seeking behavior during relapse
March 19, 2019 - First African-American Neuroscience Research Initiative launched to close the gap in health disparities
March 19, 2019 - Bimekizumab Demonstrated Long-Term Maintenance of Complete or Almost Complete Skin Disease Resolution for Psoriasis Patients in BE ABLE 2 Extension Study
March 19, 2019 - Attitudes about health affect how older adults engage with negative health news
March 19, 2019 - Huron Digital Pathology to unveil new ‘Scan Index Search’ platform at USCAP 2019
March 19, 2019 - Frequent intake of sugary drinks tied to greater risk of premature death
March 19, 2019 - Bruker showcases new analytical systems and applied market solutions at Pittcon 2019
March 19, 2019 - Framingham cardiovascular risk prediction model from the 1990s still gives the best results
March 19, 2019 - New article focuses on integrative health, value-based medicine, and whole systems research
March 19, 2019 - Foamix Announces FDA Acceptance of New Drug Application for FMX101 Minocycline Foam for the Treatment of Moderate-to-Severe Acne
March 19, 2019 - National survey of emergency dept management of self-harm highlights successes, room for improvement
March 19, 2019 - Scientists reverse alcohol-seeking behavior in rats with flip of a switch
March 19, 2019 - Researchers hope blood test that accurately diagnoses fibromyalgia could be available within five years
March 19, 2019 - New Planmeca ProScanner 2.0 offers fast and dependable intraoral imaging
March 19, 2019 - A new option for reducing LDL cholesterol in patients at high risk for heart attack, stroke
March 19, 2019 - Common medications to treat heartburn linked to increased risks for kidney failure
March 19, 2019 - Current HBV genome sequences help deduce ancient human population movements into Australia
March 19, 2019 - Pure omega-3 prescription drug significantly reduces the occurrence of ischemic events
March 19, 2019 - Researchers use big data to gain better understanding of hepatitis E virus
March 19, 2019 - Use of synthetic psychedelic linked to improvements in depression and anxiety
March 19, 2019 - GARP protein can be a potential target for immunotherapy against colorectal cancer
March 19, 2019 - Knee Pain Not Tied to Activity Levels in Knee Osteoarthritis
March 19, 2019 - Study shows benefits of delayed cord clamping in healthy babies
March 19, 2019 - Pharmacists can undertake overall clinical responsibility for patients, shows study
March 19, 2019 - A cell’s “self-destruct” function could yield new therapies
March 19, 2019 - Latest advances and perspectives of all AI types used in pharmaceutical R&D
March 19, 2019 - Prophylactic cranial irradiation used as standard approach for patients with NSCLC
March 19, 2019 - Sugar-sweetened beverages may be linked with increased risk of cardiovascular mortality
March 19, 2019 - AHA News: Black Woman in Their 50s Face Especially High Stroke Risk
March 19, 2019 - Secrets of early life revealed from less than half a teaspoon of blood
March 19, 2019 - Immune cells engineered to tattle on suspicious cells in the body
Long-awaited structure offers new insights into rejection of transplanted organs

Long-awaited structure offers new insights into rejection of transplanted organs

image_pdfDownload PDFimage_print

Rejection of any kind is always hard to deal with, but when one’s body rejects a precious organ transplant, the consequences can be devastating. Professor A. Vathsala, Co-director of the National University Centre for Organ Transplantation at the National University Hospital (NUH) and Professor of Medicine, shared that between 30% to 40% of kidney transplants are lost over time to rejection. She, together with Associate Professor Paul MacAry of the Department of Microbiology and Immunology at NUS Medicine, decided to collaborate on addressing one major clinical problem at NUH’s NUCOT: How to make each transplanted organ last longer?

Introducing an organ from a donor into a recipient almost always leads to the recipient’s immune system recognising the new organ as foreign and mounting an immune response. Transplant (or graft) rejection can be categorised into two main types: cell-mediated rejection and antibody-mediated rejection. Cell-mediated rejection, which occurs more commonly within the first year after a transplant, is caused by immune cells called T cells attacking the transplant. This type of rejection responds well to treatment with non-specific immunosuppressants such as steroids.

The particularly thorny issue for transplant patients is antibody-mediated rejection, which causes chronic rejection. Antibodies in the transplant patient bind to a molecule called human leukocyte antigen (HLA) on the transplanted donor organ and stimulate an inflammatory response involving either immune cells or the complement pathway. One major problem in transplantation is the difficulty in diagnosing and predicting antibody-mediated rejection. Moreover, doctors only find out that rejection has occurred when a graft starts to fail and they perform a biopsy.

“We found that up to twenty percent of patients had antibodies against their donors. Just because a patient has antibodies doesn’t mean they are going to have a rejection. Although many transplant patients have antibodies, not all antibodies are harmful and to date there is not a good way to predict which antibodies are actually harmful,” said Prof Vathsala.

Another, bigger problem is that there are no effective treatments for antibody-mediated rejection. Such patients with antibody-mediated rejection end up needing re-transplantation with a fresh organ, which is challenging given the shortage of donor organs. Hence, antibody-mediated rejection is a major challenge in organ transplantation and presents an ideal target for pushing the envelope on transplant outcomes.

A critical step in antibody-mediated rejection is the binding of antibodies in a transplant recipient to the donor HLA molecule. These antibodies are called alloantibodies. However, until now, the mechanism by which these antibodies bind to HLA was not known. In a paper published online in Nature Communications on 21 February 2019, Assoc Prof MacAry, Prof Vathsala, along with collaborators from Nanyang Technological University and Oxford University, announced the first high-resolution crystal structure of the alloantibody-HLA interaction.

At this resolution (2.4 angstroms), the researchers were able to glean several important insights. Firstly, they identified two amino acids in HLA (aspartic acid at position 90 and arginine at position 14) that were critical for the antibody-HLA binding. Secondly, they found that the antibody bound to a site at the bottom of the HLA protein, some distance away from the sites at which peptides, T cells and natural killer cells bind to HLA. This finding was surprising because it indicated that the inflammatory response stimulated by the antibody was independent of the interactions of peptides or immune cells with HLA.

“What was interesting is that the antibody binds to the side of the [HLA] molecule,” explained Assoc Prof MacAry. “What this allows you to do is design inhibitors that are going to obstruct the interface because if you stop the antibodies binding, you stop those antibodies from engendering the immune attack.”

In fact, the team showed that one form of the antibody (a subclass called IgG4) bound to the HLA protein without causing an inflammatory response. Since these antibodies are able to reduce inflammation by binding to HLA and preventing other antibody subclasses from binding, they could be developed as therapies for prevention or treatment of antibody-mediated rejection.

According to Professor Kathryn Wood, Emeritus Professor of Immunology at the University of Oxford and the Khoo Oon Teik Professor of Surgery at NUS Medicine, who was an advisor for the project and a co-author on the Nature Communications paper, this is a “landmark study that all groups around the world will take note of. It’s really a first in this field.”

The crystal structure is of just one type of HLA called HLA-A*11:01, which is common amongst Chinese and the most common type in Singaporeans. In the next three to five years, the team hopes to solve the structures of all other HLA molecules that are common in Asians.

Prof Vathsala described the project as a serendipitous collaboration of basic science and clinical research to solve a longstanding problem in the clinic. “We [at NUH] have a wonderful campus in our backyard where we can meet with experts from Microbiology and Immunology. The project grew out of a chance tea where Paul and I met and said, ‘Let’s solve this problem and look at the structural aspects of antibody and antigen.'”

Source:

https://nusmedicine.nus.edu.sg/

Tagged with:

About author

Related Articles